Total Payments
$12,315
2024 Payments
$720.04
Companies
40
Transactions
543
Medicare Patients
6,076
Medicare Billing
$408,498
Payment Breakdown by Category
Food & Beverage$12,198 (99.1%)
Education$116.76 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,198 | 541 | 99.1% |
| Education | $116.76 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,638 | 79 | $0 (2024) |
| Lilly USA, LLC | $1,013 | 49 | $0 (2024) |
| PFIZER INC. | $989.72 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $968.55 | 47 | $0 (2024) |
| GENZYME CORPORATION | $860.40 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $805.53 | 44 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $667.47 | 33 | $0 (2024) |
| Amgen Inc. | $644.18 | 29 | $0 (2024) |
| Celgene Corporation | $564.30 | 17 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $563.89 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $720.04 | 36 | ABBVIE INC. ($156.43) |
| 2023 | $1,315 | 55 | Verrica Pharmaceuticals Inc. ($183.68) |
| 2022 | $1,273 | 51 | ABBVIE INC. ($283.70) |
| 2021 | $1,186 | 61 | Ortho Dermatologics, a division of Bausch Health US, LLC ($185.91) |
| 2020 | $1,159 | 47 | AbbVie Inc. ($207.33) |
| 2019 | $2,453 | 107 | AbbVie, Inc. ($363.34) |
| 2018 | $2,031 | 90 | Lilly USA, LLC ($227.99) |
| 2017 | $2,177 | 96 | AbbVie, Inc. ($263.74) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.12 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $33.96 | General |
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.08 | General |
| Category: Dermatology | ||||||
| 06/12/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ACNE | ||||||
| 06/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 05/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Dermatology | ||||||
| 05/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: DERMATOLOGY | ||||||
| 04/09/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Immunology | ||||||
| 04/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,164 | 2,198 | $410,045 | $84,369 |
| 2022 | 13 | 1,360 | 2,463 | $474,610 | $100,369 |
| 2021 | 12 | 1,686 | 3,135 | $574,633 | $120,878 |
| 2020 | 15 | 1,866 | 3,046 | $375,235 | $102,882 |
Total Patients
6,076
Total Services
10,842
Medicare Billing
$408,498
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 500 | 641 | $128,775 | $38,478 | 29.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 381 | 512 | $153,600 | $19,194 | 12.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 164 | $37,775 | $14,908 | 39.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 165 | 193 | $67,550 | $14,639 | 21.7% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 84 | 95 | $33,250 | $8,482 | 25.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 250 | 1,298 | $64,900 | $6,384 | 9.8% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 19 | 22 | $25,040 | $4,630 | 18.5% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 12 | 12 | $13,068 | $4,527 | 34.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 88 | 101 | $15,200 | $3,619 | 23.8% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 22 | 26 | $19,450 | $2,148 | 11.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 41 | 53 | $9,275 | $2,034 | 21.9% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 15 | 18 | $6,750 | $1,834 | 27.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 581 | 735 | $91,192 | $34,029 | 37.3% |
| 17000 | Destruction of skin growth | Office | 2020 | 393 | 491 | $79,315 | $18,044 | 22.7% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 120 | 134 | $32,155 | $11,357 | 35.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 146 | 155 | $31,136 | $10,422 | 33.5% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 29 | 29 | $16,550 | $6,630 | 40.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 142 | 177 | $15,914 | $5,007 | 31.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 263 | 1,119 | $62,548 | $4,818 | 7.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 42 | $8,050 | $2,851 | 35.4% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 20 | 21 | $7,756 | $2,334 | 30.1% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2020 | 26 | 28 | $14,000 | $2,224 | 15.9% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 38 | 42 | $4,419 | $1,651 | 37.4% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 28 | 28 | $4,620 | $1,038 | 22.5% |
| 11105 | Punch biopsy of additional skin lesion | Office | 2020 | 18 | 21 | $2,595 | $989.99 | 38.1% |
About Dr. Joseph Newmark, M.D
Dr. Joseph Newmark, M.D is a Dermatology healthcare provider based in Vestal, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902939317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Newmark, M.D has received a total of $12,315 in payments from pharmaceutical and medical device companies, with $720.04 received in 2024. These payments were reported across 543 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($12,198).
As a Medicare-enrolled provider, Newmark has provided services to 6,076 Medicare beneficiaries, totaling 10,842 services with total Medicare billing of $408,498. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Vestal, NY
- Active Since 03/14/2007
- Last Updated 03/11/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902939317
Products in Payments
- EUCRISA (Drug) $973.43
- TALTZ (Drug) $896.33
- COSENTYX (Biological) $691.41
- Tremfya (Drug) $609.94
- SKYRIZI (Biological) $530.88
- Enbrel (Biological) $512.85
- Humira (Biological) $493.68
- Otezla (Drug) $477.64
- SILIQ (Drug) $444.80
- DUPIXENT (Drug) $440.26
- DUPIXENT (Biological) $402.59
- OPZELURA (Drug) $346.23
- ILUMYA (Biological) $276.30
- Cimzia (Drug) $268.24
- STELARA (Biological) $261.83
- TREMFYA (Drug) $249.89
- COSENTYX (Drug) $237.08
- REMICADE (Biological) $214.84
- RINVOQ (Biological) $185.16
- YCANTH (Drug) $183.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Vestal
Dr. Colleen Crandell, D.o, D.O
Dermatology — Payments: $5,503
Dermatology $5,503
Romeo Morales, Md, MD
Dermatology — Payments: $3,061
Dermatology $3,061
Ayyaz Shah, Do, DO
Dermatology — Payments: $1,617
Dermatology $1,617
Shelly Rivas, M.d, M.D
Dermatology — Payments: $1,371
Dermatology $1,371
Dr. Uzoma Oranu, M.d, M.D
Dermatology — Payments: $992.30
Dermatology $992.30
Catalina Dailey, Fnp-C, FNP-C
Dermatology — Payments: $427.62
Dermatology $427.62